Xiaoli Feng

10.2k total citations
155 papers, 3.4k citations indexed

About

Xiaoli Feng is a scholar working on Molecular Biology, Oncology and Immunology. According to data from OpenAlex, Xiaoli Feng has authored 155 papers receiving a total of 3.4k indexed citations (citations by other indexed papers that have themselves been cited), including 54 papers in Molecular Biology, 30 papers in Oncology and 29 papers in Immunology. Recurrent topics in Xiaoli Feng's work include RNA modifications and cancer (15 papers), Lymphoma Diagnosis and Treatment (15 papers) and Immune Cell Function and Interaction (10 papers). Xiaoli Feng is often cited by papers focused on RNA modifications and cancer (15 papers), Lymphoma Diagnosis and Treatment (15 papers) and Immune Cell Function and Interaction (10 papers). Xiaoli Feng collaborates with scholars based in China, United States and Hong Kong. Xiaoli Feng's co-authors include Longquan Shao, Jie He, Susheng Shi, Aijie Chen, Chengyun Zheng, Jianguo Su, Yibo Gao, Yanli Zhang, Youliang Rao and Bengt Fadeel and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and SHILAP Revista de lepidopterología.

In The Last Decade

Xiaoli Feng

149 papers receiving 3.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Xiaoli Feng China 34 1.2k 767 605 521 409 155 3.4k
Majid Ahmadi Iran 40 1.3k 1.1× 454 0.6× 1.3k 2.1× 479 0.9× 191 0.5× 103 4.2k
Guangying Cui China 33 2.1k 1.7× 588 0.8× 358 0.6× 729 1.4× 145 0.4× 82 3.4k
Shivani Soni United States 24 915 0.7× 1.1k 1.4× 837 1.4× 353 0.7× 285 0.7× 112 3.2k
Xiangmei Chen China 40 2.2k 1.7× 552 0.7× 474 0.8× 1.1k 2.1× 172 0.4× 202 5.2k
Aiping Tong China 38 2.3k 1.8× 1.5k 2.0× 881 1.5× 440 0.8× 180 0.4× 174 5.1k
Yi Zeng China 26 1.0k 0.8× 863 1.1× 277 0.5× 594 1.1× 196 0.5× 78 2.9k
Subramanian Krishnakumar India 34 1.7k 1.4× 796 1.0× 402 0.7× 498 1.0× 158 0.4× 256 4.4k
Karen Smith United States 33 1.7k 1.3× 693 0.9× 802 1.3× 546 1.0× 169 0.4× 103 4.9k
Fangfang Guo China 25 1.6k 1.3× 623 0.8× 188 0.3× 373 0.7× 188 0.5× 58 3.2k
Hamed Mohammadi Iran 35 1.3k 1.1× 733 1.0× 1.4k 2.3× 569 1.1× 130 0.3× 130 3.9k

Countries citing papers authored by Xiaoli Feng

Since Specialization
Citations

This map shows the geographic impact of Xiaoli Feng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaoli Feng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaoli Feng more than expected).

Fields of papers citing papers by Xiaoli Feng

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xiaoli Feng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaoli Feng. The network helps show where Xiaoli Feng may publish in the future.

Co-authorship network of co-authors of Xiaoli Feng

This figure shows the co-authorship network connecting the top 25 collaborators of Xiaoli Feng. A scholar is included among the top collaborators of Xiaoli Feng based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xiaoli Feng. Xiaoli Feng is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zhang, Daqi, Ge Li, Zhong-guo Fu, et al.. (2025). Irisin ameliorates cognitive impairment in a lipopolysaccharide-induced neuroinflammation mouse model by inhibiting the NLRP3 inflammasome pathway in microglia. Neuropharmacology. 278. 110572–110572. 1 indexed citations
2.
Feng, Xiaoli, Fengwei Tan, Qi Xue, et al.. (2025). Multi‐omics analyses reveal distinct molecular characteristics and transformation mechanisms of stage I–III micropapillary lung adenocarcinoma. The Journal of Pathology. 266(2). 204–216. 1 indexed citations
3.
Wang, Xinyue, Changfa Xia, Yong-Wen Song, et al.. (2024). Multicenter Phase Ii Study of Moderate Low-Dose Radiotherapy in Indolent Non-Hodgkin Lymphoma: CLCG-iNHL-01 Protocol. Future Oncology. 20(2). 71–81. 2 indexed citations
4.
Ren, Jing, Qian Zhou, Yanan Guo, et al.. (2024). Lactate dehydrogenase A is implicated in the pathogenesis of B‐cell lymphoma through regulation of the FER signaling pathway. BioFactors. 50(5). 1024–1038. 2 indexed citations
5.
Li, Qian, Yunqing Huang, Xiaoli Feng, et al.. (2023). Biodecolorization of Cationic Red X-GRL by Immobilized Shewanella oneidensis MR-1. Water Air & Soil Pollution. 234(4). 3 indexed citations
6.
Guo, Yanan, Yongjing Wang, Juan Xiao, et al.. (2023). GSK‐3β/β‐catenin pathway plays crucial roles in the regulation of NK cell cytotoxicity against myeloma cells. The FASEB Journal. 37(3). e22821–e22821. 5 indexed citations
7.
8.
Hu, Chen, Yujun Yang, Yuqing Lin, et al.. (2021). GO-based antibacterial composites: Application and design strategies. Advanced Drug Delivery Reviews. 178. 113967–113967. 74 indexed citations
9.
Kang, Yiyuan, Jia Liu, Suhan Yin, et al.. (2020). Oxidation of Reduced Graphene Oxide via Cellular Redox Signaling Modulates Actin-Mediated Neurotransmission. ACS Nano. 14(3). 3059–3074. 34 indexed citations
10.
Xu, Yaqi, Qian Zhou, Xiaoli Feng, et al.. (2020). Disulfiram/copper markedly induced myeloma cell apoptosis through activation of JNK and intrinsic and extrinsic apoptosis pathways. Biomedicine & Pharmacotherapy. 126. 110048–110048. 41 indexed citations
11.
Lai, Xuan, Menglei Wang, Xiaoli Feng, et al.. (2020). ZnO NPs delay the recovery of psoriasis-like skin lesions through promoting nuclear translocation of p-NFκB p65 and cysteine deficiency in keratinocytes. Journal of Hazardous Materials. 410. 124566–124566. 38 indexed citations
12.
Zhang, Xin, Yujing Fang, Xiaoli Feng, et al.. (2020). Interactions Between Vitamin D and Calcium Intake, Vitamin D Receptor Genetic Polymorphisms, and Colorectal Cancer Risk. Digestive Diseases and Sciences. 66(6). 1895–1905. 6 indexed citations
13.
Ma, Hongzhong, et al.. (2015). Hesperetin attenuates ventilator-induced acute lung injury through inhibition of NF-κB-mediated inflammation. European Journal of Pharmacology. 769. 333–341. 35 indexed citations
14.
Feng, Xiaoli, et al.. (2014). Influence of mesoporous silica coating treatment on push-out bond strength of zirconia posts. Bio-Medical Materials and Engineering. 24(6). 2187–2195. 3 indexed citations
15.
Wang, Xiangling, Xiaoli Feng, Na Shao, et al.. (2013). Bortezomib and IL-12 produce synergetic anti-multiple myeloma effects with reduced toxicity to natural killer cells. Anti-Cancer Drugs. 25(3). 282–288. 11 indexed citations
16.
Zhao, Xiaohong, Jiwen Wang, Zhen Wang, et al.. (2010). microRNA-92a Promotes Lymph Node Metastasis of Human Esophageal Squamous Cell Carcinoma via E-Cadherin. Journal of Biological Chemistry. 286(12). 10725–10734. 125 indexed citations
17.
Ottosson, Anders, Chunyan Ji, Xiaoli Feng, et al.. (2009). Proteasome inhibition induces apoptosis in primary human natural killer cells and suppresses NKp46-mediated cytotoxicity. Haematologica. 94(4). 470–478. 32 indexed citations
18.
Chen, Yan, et al.. (2009). Angiogenesis of renal cell carcinoma: perfusion CT findings. Abdominal Imaging. 35(5). 622–628. 70 indexed citations
19.
Feng, Xiaoli, Ling Li, Yanning Gao, et al.. (2007). Fhit protein expression in lung cancer studied by high-throughput tissue microarray.. PubMed. 94(3). E8–11. 3 indexed citations
20.
Liu, Yan, Wenyue Sun, Kaitai Zhang, et al.. (2007). Identification of genes differentially expressed in human primary lung squamous cell carcinoma. Lung Cancer. 56(3). 307–317. 74 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Majid Ahmadi Breakdown of academic impact, for papers by Guangying Cui Breakdown of academic impact, for papers by Shivani Soni Breakdown of academic impact, for papers by Xiangmei Chen Breakdown of academic impact, for papers by Aiping Tong Breakdown of academic impact, for papers by Yi Zeng Breakdown of academic impact, for papers by Subramanian Krishnakumar Breakdown of academic impact, for papers by Karen Smith Breakdown of academic impact, for papers by Fangfang Guo Breakdown of academic impact, for papers by Hamed Mohammadi
Rankless by CCL
2026